1. Home
  2. CNSP vs SHFS Comparison

CNSP vs SHFS Comparison

Compare CNSP & SHFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNS Pharmaceuticals Inc.

CNSP

CNS Pharmaceuticals Inc.

N/A

Current Price

$3.07

Market Cap

2.1M

Sector

Health Care

ML Signal

N/A

Logo SHF Holdings Inc.

SHFS

SHF Holdings Inc.

N/A

Current Price

$0.82

Market Cap

3.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CNSP
SHFS
Founded
2017
2015
Country
United States
United States
Employees
4
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.1M
3.0M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
CNSP
SHFS
Price
$3.07
$0.82
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$20.00
N/A
AVG Volume (30 Days)
18.4K
67.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.22
52 Week High
$10.59
$9.18

Technical Indicators

Market Signals
Indicator
CNSP
SHFS
Relative Strength Index (RSI) 34.77 40.88
Support Level $0.86 $0.80
Resistance Level $8.89 $1.03
Average True Range (ATR) 0.29 0.09
MACD 0.11 0.01
Stochastic Oscillator 23.38 24.67

Price Performance

Historical Comparison
CNSP
SHFS

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

About SHFS SHF Holdings Inc.

SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring, among others.

Share on Social Networks: